ArticlePharmacoEconomics2018
Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?
Fernando Antoñanzas et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it